Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
tumour infiltrating lymphocytes (1 trial)
Pancreatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)